MA
PCRX icon

MCF Advisors’s Pacira BioSciences PCRX Stock Holding History

MCF Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50
Closed -$1.43K – 1049
2024
Q2 		$1.43K Hold
50
– – ﹤0.01% 874
2024
Q1 		$1.46K Hold
50
– – ﹤0.01% 846
2023
Q4 		$1.69K Buy
+50
New +$1.46K ﹤0.01% 796
2017
Q1 		– Sell
-200
Closed -$6K – 477
2016
Q4 		$6K Hold
200
– – ﹤0.01% 358
2016
Q3 		$7K Hold
200
– – ﹤0.01% 355
2016
Q2 		$7K Hold
200
– – ﹤0.01% 380
2016
Q1 		$11K Hold
200
– – ﹤0.01% 318
2015
Q4 		$15K Buy
+200
New +$11.3K ﹤0.01% 292

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return